Conference milestone

Gastric Cancer Gets a New Biomarker Access Signal

Cardio-oncology demand is rising, but training gaps are holding systems back

MRD Testing Moves From Prognosis Toward Treatment Action

Narcolepsy Treatment Starts Targeting the Cause

Optic Neuritis Moves Into the Neuroprotection Race

Cancer Is Chaos. Patients Should Not Have to Become Their Own Operating System

ALS Survival Data Return to the Evidence Debate

Can AstraZeneca challenge the obesity market leaders? New GLP-1 data signal growing ambitions beyond oncology

GIST Care Looks Beyond First-Generation KIT Control
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
